AU2003273096A1 - Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same - Google Patents

Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same

Info

Publication number
AU2003273096A1
AU2003273096A1 AU2003273096A AU2003273096A AU2003273096A1 AU 2003273096 A1 AU2003273096 A1 AU 2003273096A1 AU 2003273096 A AU2003273096 A AU 2003273096A AU 2003273096 A AU2003273096 A AU 2003273096A AU 2003273096 A1 AU2003273096 A1 AU 2003273096A1
Authority
AU
Australia
Prior art keywords
preventing
same
pharmaceutical compositions
compositions containing
furan derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273096A
Other languages
English (en)
Other versions
AU2003273096A8 (en
Inventor
Bum Tae Kim
Jong Yeo Kim
Jung-Keun Kim
Se-Won Kim
Seon Yle Ko
Byung-Eui Lee
Yeon Soo Lee
Yong Ki Min
Kwi-Ok Oh
No Kyun Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Research Institute of Chemical Technology KRICT
Oscotec Inc
Original Assignee
Oscotec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR10-2003-0072536A external-priority patent/KR100528176B1/ko
Application filed by Oscotec Inc filed Critical Oscotec Inc
Publication of AU2003273096A8 publication Critical patent/AU2003273096A8/xx
Publication of AU2003273096A1 publication Critical patent/AU2003273096A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C07D307/48—Furfural

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2003273096A 2002-10-22 2003-10-22 Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same Abandoned AU2003273096A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20020064670 2002-10-22
KR10-2002-0064670 2002-10-22
KR10-2003-0072536 2003-10-17
KR10-2003-0072536A KR100528176B1 (ko) 2002-10-22 2003-10-17 골다공증 예방 및 치료효과를 갖는 퓨란 유도체 및 이를포함하는 약학적 조성물
PCT/KR2003/002231 WO2004037804A1 (en) 2002-10-22 2003-10-22 Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same

Publications (2)

Publication Number Publication Date
AU2003273096A8 AU2003273096A8 (en) 2004-05-13
AU2003273096A1 true AU2003273096A1 (en) 2004-05-13

Family

ID=36729279

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273096A Abandoned AU2003273096A1 (en) 2002-10-22 2003-10-22 Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same

Country Status (4)

Country Link
US (1) US20060004088A1 (https=)
JP (1) JP2006515276A (https=)
AU (1) AU2003273096A1 (https=)
WO (1) WO2004037804A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1745062T3 (pl) * 2004-04-22 2014-10-31 Regado Biosciences Inc Ulepszone modulatory czynników krzepnięcia
US8247582B2 (en) * 2006-02-07 2012-08-21 Battelle Memorial Institute Esters of 5-hydroxymethylfurfural and methods for their preparation
US8293720B2 (en) * 2007-12-20 2012-10-23 Dogwood Pharmaceuticals, Inc. Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
EA201270102A1 (ru) 2009-06-30 2012-08-30 Форест Лэборетериз Холдингз Лимитед Соединения алкокси-карбонил-амино-алкинил-аденозина и их производные в качестве агонистов ar
CN103040803A (zh) * 2013-01-25 2013-04-17 南通大学 5-羟甲基-2-糠醛及其衍生物在制备预防和治疗骨代谢异常疾病的药物组合物中的应用
CA2931552A1 (en) * 2013-12-19 2015-06-25 Archer Daniels Midland Company Sulfonates of furan-2,5-dimethanol and (tetrahydrofuran-2,5-diyl)dimethanol and derivatives thereof
CN106660935A (zh) * 2014-05-12 2017-05-10 微麦德斯公司 从5‑(卤甲基)糠醛产生化合物的方法
WO2016191682A1 (en) * 2015-05-28 2016-12-01 The Regents Of The University Of California Preparation of acid chlorides from 5-(chloromethyl) furfural
CN108349920A (zh) 2015-09-17 2018-07-31 微麦德斯公司 呋喃醛上的氧化化学
CN105566260B (zh) * 2015-12-03 2018-02-16 常州亚邦制药有限公司 一种呋塞米的制备方法
CN113149941A (zh) * 2020-01-22 2021-07-23 中国科学院上海药物研究所 醚类化合物及其在防治糖尿病及代谢综合征中的药学用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1052507A (https=) * 1963-06-26
US3903293A (en) * 1970-04-23 1975-09-02 Basf Ag Fungicidal substituted furancarboxylic acid cycloalkylamide
US3778512A (en) * 1970-06-23 1973-12-11 Velsicol Chemical Corp Fungicidal method utilizing furancarboxamides
DE2842243A1 (de) * 1978-09-28 1980-04-10 Hoechst Ag Furan- und thiophen-carbonsaeure-derivate und verfahren zu ihrer herstellung
JPS5914468B2 (ja) * 1980-03-26 1984-04-04 財団法人野口研究所 ５−メチル−２−フルフラ−ルの製造法
JPS5928555B2 (ja) * 1980-03-28 1984-07-13 財団法人野口研究所 ５−アシルオキシメチルフルフラ−ルの製法
JPS59227847A (ja) * 1983-06-09 1984-12-21 Toyama Chem Co Ltd Ｎ−アシル酸性アミノ酸ジアミド類およびその製造法並びにそれらを含有する抗潰瘍剤
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
JPH0285211A (ja) * 1988-03-15 1990-03-26 Tsumura & Co 新規フェネチルアルコール配糖体および免疫抑制剤
JP2575823B2 (ja) * 1988-06-29 1997-01-29 三井東圧化学株式会社 αーアミノアセトニトリル塩酸塩類の製造方法
LU87821A1 (fr) * 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
FR2687152A1 (fr) * 1992-02-07 1993-08-13 Roussel Uclaf Nouveaux esters pyrethrinouides derives d'alcool furanique ou thiophenique, leur procede de preparation et leur application comme pesticides.
JPH06128246A (ja) * 1992-10-20 1994-05-10 Mita Ind Co Ltd ヒドラゾン系化合物およびそれを用いた電子写真感光体
JPH07138187A (ja) * 1993-11-16 1995-05-30 Nippon Ham Kk 経口免疫寛容原、経口慢性関節リウマチ治療剤及び機能性食品
JP3595852B2 (ja) * 1995-06-13 2004-12-02 日本ハム株式会社 経口慢性関節リウマチ治療剤及び機能性食品
JPH11139979A (ja) * 1997-11-07 1999-05-25 Nitto Denko Corp 免疫系抑制用組成物
AU1411499A (en) * 1997-11-20 1999-06-15 Merck & Co., Inc. Para-aminomethylaryl carboxamide derivatives
JPH11279204A (ja) * 1998-03-27 1999-10-12 Sumitomo Forestry Co Ltd 免疫抑制剤
JP2000038343A (ja) * 1998-05-20 2000-02-08 Hayashibara Biochem Lab Inc 抗骨粗鬆症剤
EP1070708B1 (en) * 1999-07-21 2004-01-14 F. Hoffmann-La Roche Ag Triazole derivatives
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
MY139601A (en) * 2002-10-09 2009-10-30 Schering Corp Thiadiazoledioxides and thiadiazoleoxides as cxc-and cc-chemokine receptor ligands

Also Published As

Publication number Publication date
US20060004088A1 (en) 2006-01-05
AU2003273096A8 (en) 2004-05-13
JP2006515276A (ja) 2006-05-25
WO2004037804A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU2003291103A1 (en) Pharmaceutical composition
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
AU2003291024A1 (en) Rhodanine derivatives and pharmaceutical compositions containing them
AU2003298841A1 (en) Pharmaceutical compositions containing indistinguishable drug components
AU2003250372A1 (en) Pharmaceutical composition
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
AU2002302147A1 (en) Pharmaceutical composition
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2003273096A1 (en) Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same
AU2003284460A1 (en) Medicinal composition
IL162497A0 (en) Benzhydryl derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003280799A1 (en) Medicinal composition
IL156547A0 (en) Pharmaceutical composition containing citalopram
AU2003280678A1 (en) Medicinal composition
AUPR529701A0 (en) Pharmaceutical composition
AUPS188302A0 (en) Pharmaceutical composition
AU2002335161A1 (en) Medicinal composition
HK1070072A (en) Quinuclidine derivatives and pharmaceutical compositions containing the same
AUPS317302A0 (en) Metastable pharmaceutical compositions
AUPS124202A0 (en) Pharmaceutical composition
AUPS167102A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase